Azelastine is classified as category B in the UK, meaning animal studies have not shown risk but human data are limited. It may be used during pregnancy only if the expected benefit outweighs potential risks, and this should be decided together with a healthcare professional.
A bitter or metallic taste is a common, mild side effect of intranasal azelastine. Swallowing the taste does not affect efficacy. If the taste is bothersome, try positioning the head slightly forward after spraying to minimise drainage to the throat.
Yes, several manufacturers produce generic azelastine hydrochloride nasal sprays that contain the same active ingredient and are prescribed under the same dosing regimen. Availability may vary by pharmacy.
Astelin delivers the antihistamine directly to the nasal mucosa, providing rapid local relief with minimal systemic absorption. Oral antihistamines act throughout the body, may cause drowsiness, and often have a slower onset of action.
Yes, the two can be used concomitantly. To avoid interference, space the administrations by at least 5-10 minutes (e.g., corticosteroid in the morning, azelastine later in the day) and follow the specific instructions provided by your healthcare provider.
Before first use, aim the nozzle away from your face and press the pump until a fine mist appears (usually 5-8 actuations). This ensures the device is ready to deliver the correct dose.
Azelastine is not typically screened for in standard workplace or sports drug tests, as it is not a performance-enhancing or prohibited substance. However, always disclose any prescription medications if asked.
With the recommended dosing of one spray per nostril twice daily, a 10 ml bottle (approximately 200 sprays) will last about 3 months. After this period, the device should be discarded even if volume remains.
Yes, provided the medication is in its original labeled container and you carry a copy of the prescription. Some countries may require a doctor’s note for prescription nasal sprays, so check the destination’s regulations before travelling.
There is limited evidence supporting its effectiveness for non-allergic rhinitis. It may relieve nasal congestion, but any off-label use should be discussed with a clinician who can weigh potential benefits against the lack of formal approval.
Astelin is a prescription nasal sprayer that contains azelastine as its active ingredient. It is formulated as a 10 ml intranasal spray and belongs to the allergy-relief category of medications. In the United Kingdom, azelastine-based nasal sprays are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and are typically prescribed for the treatment of allergic rhinitis (hay fever) when other over-the-counter options are insufficient. The product is intended for adult and adolescent use; the specific brand name “Astelin” is more common in the United States, but the active component and its pharmacology are the same.
Azelastine is a second-generation antihistamine that acts as an inverse agonist at the histamine H₁ receptor. By binding to these receptors on the nasal mucosa, it reduces the activity of histamine that is released during an allergic response. This action:
Because the spray is applied directly to the nasal passages, the drug’s local bioavailability is high, while systemic absorption remains low, which limits central nervous system side effects that are more common with oral antihistamines.
Onset of symptom relief typically occurs within 15-30 minutes, with peak effect around 1-2 hours after the dose. The therapeutic effect lasts for roughly 12 hours, which is why the usual regimen involves twice-daily dosing.
Astelin is MHRA-approved for the symptomatic treatment of seasonal and perennial allergic rhinitis in patients aged 5 years and older. The medication is used when histamine-mediated nasal symptoms such as congestion, sneezing, itching, and runny nose are not adequately controlled by non-prescription remedies (e.g., saline sprays or oral antihistamines).
Typical patient populations include:
Routine laboratory monitoring is not required for azelastine nasal spray. Patients should be advised to:
This article provides educational information about Astelin (azelastine nasal spray) and is not a substitute for professional medical advice. Treatment decisions, including the use of any medication for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
